Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases
Article first published online: 18 JUN 2004
Volume 6, Issue 4, pages 250–253, July 2004
How to Cite
Khurrum Baig, M., Marquez, H., Nogueras, J. J., Weiss, E. G. and Wexner, S. D. (2004), Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases. Colorectal Disease, 6: 250–253. doi: 10.1111/j.1463-1318.2004.00607.x
- Issue published online: 18 JUN 2004
- Article first published online: 18 JUN 2004
- Received 27 May 2003; accepted 27 May 2003
- Parastomal complications;
- pyoderma gangrenosum;
- Crohn's disease;
Introduction Pyoderma gangrenosum is a rare idiopathic skin disorder associated with other diseases, including inflammatory bowel disease. The commonest site is the skin, but sometimes it can occur in the parastomal region. Most of these cases respond to treatment with systemic corticosteroids and cyclosporin or local Kenalog injections.
Methods The following are two cases of parastomal pyoderma in patients not responding to the standard measures. These patients were treated with topical tacrolimus.
Results These patients showed dramatic improvement in one week with complete resolution and re-epithelialization of skin within two weeks.
Conclusion Pyoderma gangrenosum is a difficult problem to manage and its early resolution is important. In these two reported cases, the improvement was dramatic, therefore topical tacrolimus should be considered early in the management.